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ABSTRACT 
Vinyl chloride is a human carcinogen. The characteristic tumour is the hepatic angiosarcoma, 
first observed in the 1970s in vinyl/polyvinyl chloride workers, especially in polymerization 
autoclave workers. Recent epidemiological studies demonstrate a dependence of the tumour 
incidence on both the duration and cumulative quantity of exposure. However, there is only 
limited data concerning the possible tumour latency times. Here, a case of hepatic angiosar-
coma is presented that had been exposed to vinyl chloride in a very typical way as autoclave 
worker between 1957 and 1965. The patient was incidentally diagnosed with hepatic angio-
sarcoma in April 2008. Thus, the tumour latency time, from the beginning of occupational 
vinyl chloride exposure to clinical diagnosis, was 51 years. This underlines the importance of 
a continuing medical surveillance of workers exposed to vinyl chloride, at times before its 
carcinogenicity was recognized and regulatory action could be taken. 
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INTRODUCTION AND 
BACKGROUND 
 
Vinyl chloride has been recognized as a 
human carcinogen. Case reports of hepatic 
angiosarcomas (haemangio-epitheliomas) in 
vinyl chloride-exposed workers (Block, 
1974; Creech and Johnson, 1974; Lee and 
Harry, 1974) and small epidemiological 
studies (see Kielhorn et al., 2000) were 
published in the 1970s and 1980s. It was 
confirmed that occupational vinyl chloride 
exposures having prevailed until the 1970s 
were associated with the development of 
hepatic angiosarcoma. Additional cancer 
types, particularly hepatocellular carci-
noma, have been a matter of discussion.  
Within the last 10 years, several cohort 
studies have demonstrated the increase in 
the risk of hepatic angiosarcoma with dura-
tion of exposure and/or with cumulative 
exposure to vinyl chloride (Mundt et al., 
2000; Ward et al., 2001; Pirastu et al., 
2003; Boffetta et al., 2003). In its evalua-
tion of carcinogenicity the International 
Agency for Research on Cancer (Grosse et 
al., 2007) arrived at “sufficient evidence” in 
humans that vinyl chloride causes angiosar-
coma of the liver and hepatocellular carci-
noma. The relevance of other target sites of 
carcinogenesis is still debated (Bosetti et 
al., 2003; Boffetta et al., 2003; Pirastu et 
al., 2003; Dragini and Zocchetti, 2008). 
A large proportion of the angiosarcoma 
cases observed in the 1970s was among 
cleaners of vinyl chloride polymerization 
autoclaves. These employees were regularly 
exposed to concentrations of 500-1000 ppm 
vinyl chloride at that time. Soon after intro-
duction of regulatory measures in the late 
1970s the numbers of newly diseased cases 
have dropped rapidly (Gutacker and Lel-
bach, 1977). 
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There are recent indications of geo-
graphic/ethnic differences in response to 
vinyl chloride exposures. In the United 
States (Mundt et al., 2000; Lewis and Rem-
pala, 2003) hepatic angiosarcoma was 
strongly associated with vinyl chloride ex-
posure, not with other chemicals used in the 
production of polyvinyl chloride. The par-
ticular focus on hepatic angiosarcoma was 
also evident in Europe (Hozo et al., 1996, 
1997, 2000; Ward et al., 2001; Pirastu et al., 
2003; Gennaro et al., 2008). Much in con-
trast to all studies in “Western” populations, 
a recent large study on over 3000 workers 
employed since 1950 in a vinyl chloride 
polymerization plant in Taiwan failed to 
demonstrate an increased incidence of he-
patic angiosarcoma; instead, an increased 
risk of hepatocellular carcinoma was found 
(Wong et al., 2002). By analogy to other 
industrial chemicals (Bolt et al., 2003), a 
reason for such a discrepancy could be dif-
ferent toxicokinetics, based on differences 
in the expression of the key metabolizing 
enzyme (CYP2E1), between European and 
East Asian populations. Hence, there is a 
need of further data from several regions 
and/or populations. 
The hepatic angiosarcoma of the liver 
caused by vinyl chloride is an officially 
recognized occupational disease. In Ger-
many, this applies to “BK 1302” of the of-
ficial list of occupational diseases (Thiess 
and Frentzel-Beyme, 1975). However, in 
connection with typical past exposures the 
range of the associated tumour latency time 
is still not clear.  
Literature data (Kielhorn, 2000) show 
an overall 5-fold excess of total liver cancer 
after typical past exposures to vinyl chlo-
ride, primarily due to a 45-fold excess risk 
of angiosarcoma of the liver. The number of 
vinyl chloride-associated angiosarcoma 
cases reported up to the end of 1998 was 
197 worldwide; the average latency time 
was 22 years. In 1984, a European angio-
sarcoma register was established (Hozo et 
al., 1997). 
In Germany, there has been a focus of 
vinyl chloride-associated angiosarcoma 
cases in the state of North Rhine-
Westphalia, in particular in the area of Co-
logne/Bonn. Most of these cases were po-
lymerization autoclave workers. From 1975 
on, protective measures were introduced 
that resulted in effective exposure reduc-
tions (Gutacker and Lelbach, 1977). Retro-
spectively, the course of the disease was 
followed in 21 polyvinyl chloride produc-
tion workers from this geographical area, 
covering the period from first exposure to 
diagnosis and finally to death. In 19 cases 
death was due to malignant liver tumours, 
predominantly angiosarcoma, but also cases 
of hepatocellular and cholangiocellular car-
cinoma were noted. Two workers died from 
complications of non-cirrhotic portal fibro-
sis with portal hypertension. Latency peri-
ods in workers with malignant liver dis-
eases in this group ranged from 12 to 
34 years; the mean latency time was again 
22 years, and a younger age at first expo-
sure (< 27 y) appeared accompanied by 
shorter latency periods (Lelbach, 1996). 
The present report describes a new case 
from the Cologne/Bonn area, occupation-
ally exposed to vinyl chloride in the 1950-
1970s. He contracted a hepatic angiosar-
coma in 2008. 
 
CASE DESCRIPTION 
The worker was a male person, born 
1927, of German descent. 
Working history: The person had dif-
ferent jobs (without particular chemical 
exposure) between 1941 and 1957.  
From 1957 to 1987 he was employed in 
the chemical industry in the Cologne/Bonn 
area. From 1957 to 1976 he has been 
worker and foreman in the polyvinyl chlo-
ride producing plant. Thereafter, from 1976 
to 1986, he was committed with of-
fice/administration work (without relevant 
exposure to chemicals). 
Specifically, from 1957 to 1961 he 
worked in the “autoclave room”, where 
vinyl chloride was polymerized to polyvi-
nyl chloride. From 1961 to 1962 he worked 
in “polyvinyl chloride drying”. From 1962 
to 1976 he was foreman in the entire poly-
vinyl chloride producing department.  
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Within the total time since 1957, he was 
regularly involved in autoclave cleaning 
between 1957 and 1965 (between 1961 and 
1965 to a lesser extent than before).  
According to investigations by indus-
trial hygienists of the responsible German 
Social Accident Insurance (Berufsgenos-
senschaft der chemischen Industrie), the 
working conditions in general were charac-
terized by frequent transitions of the former 
airborne concentration limit for vinyl chlo-
ride of 100 ppm. 
Medical history: In March 2008 the pa-
tient became dyspnoeic and was admitted to 
his local hospital. An embolization of the 
lung artery was diagnosed, caused by 
thrombosis of the left V. poplitea and the V. 
tibialis posterior. In the course of the diag-
nostic procedures, computer tomography 
(CT) revealed two areas within the right 
lobe of the liver that were considered sus-
pect of metastatic processes. Initially, an 
abdominal primary tumour was considered, 
but only non-specific colitis could be found, 
without any indication of malignancy. On 
April 2, 2008, a CT-driven punction of one 
of the suspicious areas in the right caudal 
liver lobe was performed. Light microscopy 
revealed necrotic areas with fibroblastic and 
pseudo-bile duct proliferations, as well as 
angioma-like changes. Additional immuno-
histochemistry revealed many parenchymal 
areas containing CD34-expressing vascular 
elements. These sinusoids also showed 
atypical expression of CD105, and cell nu-
clei were intensively marked by P54-
antibody staining. Additional Ki67 im-
muno-histochemistry stained nearly exclu-
sively the sinusoidal nuclei. This led to the 
final histological and clinical diagnosis of a 
hepatic angiosarcoma. 
 
DISCUSSION 
There is a remarkable consistency in the 
organotropism of the carcinogenicity of 
vinyl chloride between experimental ani-
mals and humans (Bolt, 2005). In principle, 
the compound presents itself as a pluripo-
tent carcinogen, in first instance directed 
towards endothelial cells (angiosarcoma), 
secondly towards parenchymal cells of the 
liver (hepatocellular carcinoma). The active 
metabolite (Kappus et al., 1975), chloro-
ethylene oxide, is formed in hepatocytes by 
CYP2E1 (El Ghissassi et al., 1998) and 
may leave these cells to act on adjacent 
sinusoidal (endothelial) cells (Ottenwälder 
and Bolt, 1980). 
The occurrence of angiosarcoma of the 
liver in persons occupationally exposed to 
vinyl chloride is very specific. This type of 
tumour is very rare on a sporadic basis. 
Besides vinyl chloride, known exposure-
related causes are arsenicals (Roth, 1957) 
and the i.v. administration of thorium diox-
ide (Thorotrast®) as an x-ray contrast me-
dium (Becker et al., 2008). The high speci-
ficity of this malignancy was the reason 
why the causality with vinyl chloride expo-
sure was evident after the first consistent 
case reports (vs.). 
The case reported here had a typical 
working history with high vinyl chloride 
exposures, specifically upon autoclave 
work, from 1957 to 1965. He had worked in 
the polyvinyl chloride producing plant from 
which the first series of cases of “vinyl 
chloride disease” in Germany was reported 
(Jühe and Lange, 1972; Jühe et al., 1973). 
Sclerodermia-like skin changes, as part of 
the “vinyl chloride disease”, had been seen 
in these cases after working periods of 3¼ 
to 11¾ years. Raynaud’s syndrome was 
observed even earlier, in one case after just 
1¾ years of working under these conditions 
(Lange and Veltman, 1977).  
In our present case, the latency time 
from the beginning of (autoclave) work 
with vinyl chloride (1957) until the clinical 
angiosarcoma diagnosis (2008) was as long 
as 51 years. Against the background of re-
ported data (vs.), this is the case with the 
longest latency time of a vinyl chloride-
associated hepatic angiosarcoma ever de-
scribed. There can be no doubt concerning 
causality, in view of the specific working 
history and the rareness and specificity of 
the tumour. 
It therefore appears necessary that all 
workers exposed to vinyl chloride under 
respective working conditions (up to the 
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late 1970s) should be kept under continuous 
medical surveillance, such as by the 
„ODIN” system established in Germany 
(Radek, 1998). 
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